Bionomics (BNO)

Download button icon Download

Bionomics (BNO): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

Bionomics (BNO.AX)


Indicator:

ELDERS FORCE INDEX


Last Signal:

BULLISH


Trading: BUY @ $0.12
Signal Strength: MEDIUM
Recommendation:

Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.


Bionomics (ASX:BNO) current price has highlighted recent buying pressure. Currently, the Elders Force Index is 424.



Elders Force Index (EFI) measures the power behind a price movement using price and volume. The indicator can also be used to identify potential reversals and price corrections. The EFI is an oscillator that fluctuates between positive and negative values above and below a Zero Line.

Calculation: Elders Force Index (EFI):
1) Close – Close yesterday x Volume;


PROFILE: Bionomics (BNO.AX)


Stock Exchange: ASX
Company: Bionomics
Ticker Codes: | BNO.AX | ASX:BNO |

About Bionomics (ASX:BNO):

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. It operates through Drug Discovery and Development, and Contract Services segments. The company's product pipeline includes BNC210, a novel and proprietary negative allosteric modulator, which is in Phase II clinical trial for the treatment of generalized anxiety disorder, as well as is in the initiation of a Phase II clinical trial in patients with post-traumatic stress disorder; BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that targets cancer stem cells; and BNC105, a vascular disrupting agent for the treatment of cancer, as well as disrupts the blood vessels that nourish tumors in cancer treatment. It also offers contract research services. The company has partnerships with Merck & Co., Inc.; Cancer Therapeutics Cooperative Research Centre; Genmab A/S; Laboratory Corporation of America (LabCorp); Athena Diagnostics; and Genetic Technologies Limited. Bionomics Limited was founded in 1998 and is based in Thebarton, Australia.

Top 10:

Elder's Force Index

Download button icon Download
Company Close Change (%) Volume Value Signal
CLQ Clean Teq Holdings 0.5 12.4 2,443,784 -2,016 BEARISH
MOY Millennium Minerals 0.21 7.9 2,367,754 -14,046 BEARISH
DWS DWS 1.26 7.7 72,437 -339 BEARISH
VTG Vita 1.16 6.9 644,761 -54,715 BEARISH
PSI Pacific Strategic Investments 2.56 4.5 7,184 -4,767 BEARISH
RIC Ridley Corporation 1.44 3.6 292,560 -679,907 BEARISH
MNY Money3 1.72 3.6 353,313 -13,554 BEARISH
MNF My Net Fone 4.12 3.5 1,304 -2,735 BEARISH
CIA Champion Iron 1.19 3.5 57,450 -20,575 BEARISH
ISX Isignthis 0.15 3.4 20,667 -19,388 BEARISH
back to top